Celldex Therapeutics, Inc.
NASDAQ: CLDX
$25.45
-$0.79 (-3.0%)
Closing price September 22, 2023
Monday’s top analyst upgrades and downgrades included American Express, Capital One, Levi Strauss, Pinterest, Peloton, Synchrony and T-Mobile.
2 years ago
Last Updated: 2 years ago
Here, 24/7 Wall St. has included a calendar of some of the biggest companies expecting clinical trial and U.S. Food and Drug Administration (FDA) updates in February and March.
4 years ago
Last Updated: 3 years ago
Ambev, Renren, Celldex, and Yatra Online all posted new 52-week lows Friday.
5 years ago
Last Updated: 3 years ago
General Electric, Starbucks, General Dynamics, and Celldex all posted new 52-week lows Thursday.
5 years ago
Last Updated: 3 years ago
Oracle, Starbucks, Helios and Matheson, and Celldex all posted new 52-week lows Wednesday.
5 years ago
Last Updated: 3 years ago
Banco Bradesco, Gogo, Tesaro, and Celldex all posted new 52-week lows Wednesday.
5 years ago
Last Updated: 3 years ago
J.C. Penney, Helios and Matheson, Celldex, and Spectra Energy Partners all posted new 52-week lows Tuesday.
5 years ago
Last Updated: 3 years ago
MGIC Investment Group, Celldex Therapeutics, Juniper Networks, and Healthcare Services Group all posted new 52-week lows on Wednesday.
5 years ago
Last Updated: 3 years ago
Celldex Therapeutics, Acacia Communications, Apricus Biosciences, and Ctrp.com all posted new 52-week lows Monday.
5 years ago
Last Updated: 3 years ago
Celldex Therapeutics shares were absolutely crushed on Monday morning after the firm announced results to its midstage breast cancer study.
5 years ago
Last Updated: 3 years ago
Jefferies has compiled a list of over 30 biotech events taking place in 2018 that could result in significant stock moves. Some stocks have the potential to double or even crater, should a study be...
5 years ago
Last Updated: 3 years ago
The top analyst upgrades, downgrades and other research calls include American Airlines, Boeing, Cabot Oil & Gas, Pandora Media, Southern Co. and Vertex Pharmaceuticals.
6 years ago
Last Updated: 3 years ago
Macy's, Tegna, Celldex, and DryShips posted new 52-week lows Tuesday.
6 years ago
Last Updated: 3 years ago
Celldex Therapeutics was another big mover coming out of the Annual Meeting for the American Society of Clinical Oncology (ASCO). Unfortunately, the move was to the downside.
6 years ago
Last Updated: 3 years ago
24/7 Wall St. has collected several big FDA decisions and mid-stage to late-stage trials that should be announced in October.
6 years ago
Last Updated: 3 years ago